Information Library
Results for: Cost control/reduction - Partnership Structures
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Focused Co-Promotion
Case Study — May 9, 2010
Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth. -
QUINTILES OPENS EXPANDED ASIA-PACIFIC HEADQUARTERS IN SINGAPORE
Press Release — November 6, 2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles announced the official grand opening of its expanded Asia-Pacific regional headquarters facility in Singapore's Science Park I.
-
QUINTILES ANNOUNCES CLINICAL RESEARCH PARNERSHIP WITH THE UNIVERSITY OF PRETORIA
Press Release — September 10, 2009 – Quintiles Prime Site Program expands into South Africa to accelerate clinical development.
-
Anatomy of a Managed Partnership
Hear from the Experts — May 26, 2009
Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs. -
Gain Capital & Retain Value
Case Study — March 24, 2009
Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product. -
Matching Risks with Rewards
Case Study — March 24, 2009
A global pharmaceutical company had a new formulation of a core strategic asset half way through its pivotal Phase III studies, but another major product launch at the company was generating such significant expenses that it was squeezing the budget for this and other development programs.
Page 1 of 1 (6 results)
